H. Lyon

Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial.

N. Lennon, A. Giobbie-Hurder, R. Mak, 2022, The Lancet. Oncology.

Effects of Soil Conditioning by Bromus tectorum on Decomposition Rates of Plant Litter and Soil Properties

H. Lyon, 2019 .

Harmonizing Clinical Sequencing and Interpretation for the eMERGE III Network.

Robert C. Green, Keith Marsolo, Casey Overby Taylor, 2019, American journal of human genetics.

The impact of case formulation meetings for teams

C. Whitton, H. Lyon, M. Small, 2016 .

Estimation and Tests of Haplotype-Environment Interaction when Linkage Phase Is Ambiguous

N. Laird, E. Silverman, D. Schaid, 2003, Human Heredity.

Abstract CT142: GD2.Ox40.CD28.z CAR T cell trial in neuroblastoma and osteosarcoma

A. Gentles, H. Maecker, B. Sahaf, 2022, Cancer Research.